PROFOUND MEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.88 CAD | +0.65% |
|
-5.56% | -1.98% |
| 05-15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
| 05-14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Presenter SpeechArun Menawat (Executives)It is now 10:00 a.m., and I will ask that this meetin...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
10.88
CAD
Average target price
12.5
CAD
Spread / Average Target
+14.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.98% | 194M | |
| +11.31% | 226B | |
| +15.50% | 198B | |
| +18.83% | 142B | |
| +30.38% | 111B | |
| +3.00% | 65.26B | |
| +18.31% | 54.36B | |
| +4.96% | 50.94B | |
| +9.95% | 44.8B | |
| +4.27% | 36.8B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Transcript : Profound Medical Corp. - Shareholder/Analyst Call
